===
EQS-News: MEDICLIN AG / Key word(s): AGM/EGM
MEDICLIN: Annual General Meeting of MEDICLIN AG approves all proposed resolutions
2024-06-10 / 09:48 CET/CEST
The issuer is solely responsible for the content of this announcement.
Annual General Meeting of MEDICLIN AG approves all proposed resolutions
Offenburg, 10 June 2024: MEDICLIN Aktiengesellschaft (MEDICLIN) held its Annual General Meeting on Thursday, 6^th of
June. This was held as a virtual Annual General Meeting without the physical presence of shareholders or their
authorised representatives (with the exception of the company's proxies) in Bad Neustadt an der Saale.
CEO Dr Joachim Ramming expressed his satisfaction with the past financial year 2023. The post-acute segment in
particular, which reflects the core competence of rehabilitation, recorded a successful development. This development
is to be built on further this year.
The Supervisory Board was also satisfied with the 2023 financial year. With the newly acquired Supervisory Board
members PD Dr Sara Sheikhzadeh, Mr Hafid Rifi and Mr Joachim Gemmel, the Board has been strengthened by experienced
members. Dr Jan Liersch, Chairman of the Supervisory Board of MEDICLIN, comments: "We are looking forward to working
with our new Supervisory Board members. They bring valuable experience and are a clear asset to the Supervisory Board
of MEDICLIN AG".
The healthcare industry is facing major challenges
The situation for healthcare professionals remains tense. The demand for skilled labour will continue to grow faster
than the supply. This shortage of skilled labour will make it more difficult to provide patients with the best possible
care. Added to this is the pending hospital reform. It primarily affects the acute sector, but is expected to have an
impact on all areas of the healthcare system, including rehabilitation. Dr Joachim Ramming, CEO of MEDICLIN, commented
on the potential effects: "Hospitals will have to adapt their portfolios. Beds in the stationary sector will be reduced
throughout Germany and ambulatory care will continue to increase."
Information on the Annual General Meeting
All resolutions proposed by the management were approved by a majority. 92.11% of the share capital was represented at
the Annual General Meeting. The resolution on the retention of net retained profits was approved by a majority of
99.99%. In addition to the discharge of the Executive Board and Supervisory Board with majorities of 98.37% and 98.16%
respectively, the election of new Supervisory Board members was also on the agenda. Mr Michael Bock, Dr Julia
Dannath-Schuh and Ms Cornelia Wolf were re-elected to the Supervisory Board. Mr Hafid Rifi and Ms PD Dr Sara
Sheikhzadeh were also elected to the Supervisory Board. Mr Joachim Gemmel, who was already appointed to the Supervisory
Board of MEDICLIN AG by the Freiburg District Court in March 2024 until the Annual General Meeting, has also been
elected to the Supervisory Board. KPMG AG Wirtschaftsprüfungsgesellschaft was appointed as auditor and Group auditor
for the 2024 financial year with a majority of 98.83%. The Annual General Meeting approved a new remuneration system
for the Executive Board with a majority of 96.98%.
All voting results can be viewed under the following link (German only).
MEDICLIN will publish its interim report for the first half of 2024 on 31 July.
For further information:
MEDICLIN Aktiengesellschaft
Okenstrasse 27
77652 Offenburg
Investor Relations
Ender Gülcan, CIIA, CESGA
Phone: 0781/488-326
ender.guelcan@mediclin.de
Public Relations
Dr Janina Lossen
Phone: 0781/488-180
janina.lossen@mediclin.de
www.mediclin.de
About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)
MEDICLIN includes 32 clinics, six care facilities and ten medical care centers. The Group has around 8,300 beds/care
places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the
first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors,
therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people
in need of care according to their individual needs and personal needs.
MEDICLIN a company of the Asklepios Group

2024-06-10 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      MEDICLIN AG 

Okenstraße 27
77652 Offenburg
Germany

Phone:        +49 (0)781 488-326 
Fax:          +49 (0)781 488-184 
E-mail:       ender.guelcan@mediclin.de 
Internet:     www.mediclin.de 
ISIN:         DE0006595101 
WKN:          659510 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 

Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1921511

End of News EQS News Service
===
1921511 2024-06-10 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1921511&application_name=news

END) Dow Jones Newswires

June 10, 2024 03:49 ET (07:49 GMT)